Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme

World News: . []

Captozyme Inc announced today that it is initiating a prospective double-blind randomized placebo controlled cross-over study with Nephure an oxalate reducing enzyme to determine the extent to which Nephure vs placeb...

More news and information about Captozyme, Inc.

Published By:

Business Wire: 19:00 GMT Wednesday 11th July 2018

Published: .

Search for other references to "captozyme" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us